Becton Dickinson Recalls BD Spinal Trays
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Becton Dickinson & Company is recalling 3,130 units of BD Spinal Trays nationwide due to quality issues with the included bupivacaine component.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 10, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Medical Devices.
What Happened
Becton Dickinson & Company initiated a voluntary recall of certain BD Spinal Trays. This is a sub-recall stemming from quality issues identified at Huons Co, Ltd., the manufacturer of the Bupivacaine Hydrochloride in Dextrose Injection, USP component, related to acceptance testing deficiencies during an FDA facility inspection.
Which Products Are Affected
The recall covers BD Spinal Tray with BD Quincke Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose (8.25%), 2 mL (marcaine). Catalog Numbers: 405621, 405735. A total of 3,130 units are affected. Distribution was nationwide to AK, AL, AR, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, MS, NC, NE, NH, NJ, NV, NY, OH, OR, PA, PR, SD, TN, TX, UT, VA, WA, WI, WV, WY. Specific lots include:
- Catalog 405621: Lot B01V142D (exp. 2026-06-01), Lot B01V176D (exp. 2026-06-28)
- Catalog 405735: Lot B01V149D (exp. 2026-06-01), Lot B01V190D (exp. 2026-10-01) Recall number Z-2249-2026. Classification: Class I.
What You Should Do
Consumers and healthcare facilities should follow guidance from the recalling firm regarding the affected products.
Why This Matters
The recall involves spinal anesthesia trays distributed across the United States, with potential implications for product quality in medical procedures.
Source
FDA recall Z-2249-2026. https://www.fda.gov
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,402 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to July 10, 2026.
Frequently Asked Questions
Common questions about this FDA recall.